Statement on the Implications of HPTN 052 for the U.S. Response to Domestic and Global AIDS

The following policy statement responds to the results of the HPTN 052 study, sponsored by the National Institute of
Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH),which found that HIV‐infected men and
women with relatively healthy immune systems who received immediate oral antiretroviral therapy (ART) were more
than 96 percent less likely to sexually transmit the infection to their uninfected partners and were more than 40 percent
less likely to experience a clinical event than those whose treatment was delayed. The findings from the HPTN 052 study
provide further urgency to the quest to expand access to HIV treatment. These policy recommendations will be updated
to reflect significant scientific discoveries related to the prevention, care and treatment of HIV disease.

Read Full Policy Statement